<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Pharm Res</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Pharm Res</journal-id><journal-id journal-id-type="publisher-id">IJPR</journal-id><journal-title-group><journal-title>Iranian Journal of Pharmaceutical Research : IJPR</journal-title></journal-title-group><issn pub-type="ppub">1735-0328</issn><issn pub-type="epub">1726-6890</issn><publisher><publisher-name>Shaheed Beheshti University of Medical Sciences</publisher-name><publisher-loc>Tehran, Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25587314</article-id><article-id pub-id-type="pmc">4232791</article-id><article-id pub-id-type="publisher-id">ijpr-13-1249</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Effect of Sumac (<italic>Rhus coriaria </italic>L.)Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients </article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shidfar</surname><given-names>Farzad</given-names></name><xref ref-type="aff" rid="affa">a</xref></contrib><contrib contrib-type="author"><name><surname>Rahideh</surname><given-names>Seyedeh Tayebeh</given-names></name><xref ref-type="aff" rid="affa">a</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Rajab</surname><given-names>Asadollah</given-names></name><xref ref-type="aff" rid="affb">b</xref></contrib><contrib contrib-type="author"><name><surname>Khandozi</surname><given-names>Nafise</given-names></name><xref ref-type="aff" rid="affa">a</xref></contrib><contrib contrib-type="author"><name><surname>Hosseini</surname><given-names>Sharieh</given-names></name><xref ref-type="aff" rid="affc">c</xref></contrib><contrib contrib-type="author"><name><surname>Shidfar</surname><given-names>Shahrzad</given-names></name><xref ref-type="aff" rid="affd">d</xref></contrib><contrib contrib-type="author"><name><surname>Mojab</surname><given-names>Faraz</given-names></name><xref ref-type="aff" rid="affe">e</xref></contrib></contrib-group><aff id="affa"><label>a</label>Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran. </aff><aff id="affb"><label>b</label>Iranian Diabetes Association, Tehran, Iran.</aff><aff id="affc"><label>c</label>Islamic Azad University, Robat Karim Branch, Robat Karim, Iran.</aff><aff id="affd"><label>d</label>University of Massachusetts, Worcester Memorial Hospital, Worcester, Massachusetts, USA. </aff><aff id="affe"><label>e</label>School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</aff><author-notes><corresp id="cor1"><label>*</label>Email: t-rahide@razi.tums.ac.ir</corresp></author-notes><pub-date pub-type="ppub"><season>Autumn</season><year>2014</year></pub-date><volume>13</volume><issue>4</issue><fpage>1249</fpage><lpage>1255</lpage><history><date date-type="received"><month>5</month><year>2013</year></date><date date-type="accepted"><month>9</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2014 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services</copyright-statement><license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Sumac (<italic>Rhus coriaria </italic>L.) is used as an herbal remedy in traditional medicine. The aim of this study was to determine the effects of sumac (<italic>R. coriaria</italic>) on serum glycemic status, apolipoprotein (apo) B, apoA-I and total antioxidant capacity (TAC) in type 2 diabetic patients. This double blind randomized controlled clinical trial was conducted on 41type 2 diabetic volunteers randomly assigned into 3g/day sumac powder (n=22) or placebo (n=19) groups over 3 months. Blood samples were collected before and after the intervention. Serum glucose and HbA1c were measured using enzymatic and turbidimetric inhibition immunoassay methods, respectively. ApoB, apoA-I and TAC were determined using turbidimetric immunoassay and spectrophotometric methods, respectively. There were signi&#x0fb01;cant decreases in serum glucose and HbA1c and also apoB levels at the end of study compared with initial values (<italic>P</italic>&#x0003c; 0.0001, <italic>P</italic>= 0.002 and <italic>P</italic>&#x0003c; 0.0001,respectively). Also, there was a significant difference in HbA1c and TAC levels between placebo and sumac groups at the end of study (<italic>P</italic>&#x0003c; 0.05).In sumac group, there were significant increase in apoA-I and TAC(<italic>P</italic>&#x0003c; 0.0001) compared with initial values. The mean of differences of serum glucose, HbA1c, apoB, apoA-I, apoB/apoA-I ratio and TAC between groups were significant (<italic>P</italic>&#x0003c; 0.05). In conclusion, these results showed the favorite effect of sumac consumption on serum glycemic status, apoB, apoA-I and TAC levels in in type 2 diabetic patients.</p></abstract><kwd-group><title>Key Words</title><kwd>Sumac</kwd><kwd>Glycemic status</kwd><kwd>Apolipoprotein</kwd><kwd>Total antioxidant capacity</kwd><kwd>Diabetes</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>According to WHO reports, 180 million people suffer from diabetes worldwide (<xref rid="B1" ref-type="bibr">1</xref>). It is estimated that developing countries in Asia and in the Middle East, particularly in Persian Gulf states, will have the largest increase in the prevalence of diabetes by 2030 (<xref rid="B2" ref-type="bibr">2</xref>). The number of Iranian diabetic patients who are 25-64 years old is 7.7 percent and half of them are unaware of their condition and also 6.8 percent of adult Iranians have impaired fasting glucose (<xref rid="B3" ref-type="bibr">3</xref>). Abnormalities in carbohydrate, lipid and lipoprotein metabolism lead to hyperglycemia and many complications such hyperlipidemia, hyperinsulinemia, hypertension and atherosclerosis (<xref rid="B4" ref-type="bibr">4</xref>). Therefore glycemic and lipids profiles and also oxidative stress control is fundamental for the management of diabetes.</p><p>Spices and herbal remedies have been used since ancient times to treat a variety of disorders (<xref rid="B5" ref-type="bibr">5</xref>). Sumac is the common name for a genus (<italic>Rhus</italic>) that contains over 250 individual species of &#x0fb02;owering plants in the family Anacardiaceae (<xref rid="B6" ref-type="bibr">6</xref>). This genus is found in temperate and tropical regions worldwide, with representative members by geographic location. This spice comes from the berries of a wild bush that grow in all Mediterranean areas (<xref rid="B7" ref-type="bibr">7</xref>). Sumac is widely used in Turkey, Iran and Arab countries as a condiment, either in pure form or in combination with other spices(<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>). In Persian traditional medicine, sumac (<italic>Rhus coriaria </italic>L.) is believed to have atheroprotective effects and is consumed in some Persian dishes (<xref rid="B7" ref-type="bibr">7</xref>). In Iran, <italic>R.coriaria</italic> is traditionally used as a table spice especially along with rich dishes and is highly recommended for adjustment of the blood lipids in diabetic patients(<xref rid="B9" ref-type="bibr">9</xref>). It is used as an herbal remedy in traditional medicine owing to its anti-&#x0fb01;brogenic, antifungal, anti-in&#x0fb02;ammatory, antimalarial, antimicrobial, antimutagenic, antioxidant, antithrombin, antitumorigenic, antiviral, cytotoxic, hypoglycaemic, leukopaenic (<xref rid="B6" ref-type="bibr">6</xref>) and atheroprotective effects (<xref rid="B10" ref-type="bibr">10</xref>). Sumac contains various substances, phenol acids and flavonoids, such as gallic acid (GA), methyl gallate, kaempferol, and quercetin (<xref rid="B11" ref-type="bibr">11</xref>). Gallic acid possesses potent antioxidant properties (<xref rid="B12" ref-type="bibr">12</xref>). Also, Sumac is known to be a rich source of hydrolysable tannins (<xref rid="B10" ref-type="bibr">10</xref>). Tannin and its derivatives are strong antioxidants (<xref rid="B7" ref-type="bibr">7</xref>). <italic>In-vitro</italic> and <italic>in-vivo</italic> studies have shown that tannins have anticarcinogenic effect (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B12" ref-type="bibr">12</xref>).</p><p>Sumac has been found to possess hypoglycaemic and hypolipidemic properties but evidence for its effects is mainly based on the results that are obtained from <italic>in-vitro </italic>experiments and animal studies and we didn't find any human study about the effect of sumac on them. One of our primitive concerns is that extrapolating it to humans <italic>in-vivo</italic>. Mohammadi <italic>et al.</italic> reported a single dose of administration of the extract of <italic>R. coriaria </italic>fruits reduced postprandial blood glucose (PBG) significantly in rats (<xref rid="B9" ref-type="bibr">9</xref>). However, in other study<italic>, </italic>addition of sumac to the diet of rabbits had no effect on blood glucose (<xref rid="B12" ref-type="bibr">12</xref>). Sumac has reduced total cholesterol (TC), low density lipoprotein(LDL-C),triglyceride (TG) and blood sugar in animal studies (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B14" ref-type="bibr">14</xref>). </p><p>Prolonged hyperglycemia by means of the increased oxidative stress was suggested as the major cause of endothelial dysfunction, which plays a pivotal role in development of atherosclerosis (<xref rid="B15" ref-type="bibr">15</xref>). A number of <italic>in-vitro </italic>and animal investigations were published concerning antioxidant effects of sumac (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B16" ref-type="bibr">16</xref>). The only a human study was published by Chacraborty <italic>et al</italic>. Over all, the results of their study showed for the &#x0fb01;rst time that the spice sumac is a potent antioxidant which protects humans against oxidative DNA-damage and suggest that GA is may be account for sumac effects (<xref rid="B8" ref-type="bibr">8</xref>). </p><p>Recent researches have focused on new factors including apoB and apoA-I that these factors have a role in the formation of atherosclerosis. ApoB and apoA-I are more important than the LDL and high density lipoprotein (HDL) particles as a marker of atherogenic risk (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). We didn&#x02019;t find any human study about the effect of sumac on glycemic status, apolipoproteins and total antioxidant capacity (TAC). In this present study, we have investigated the effects of sumac (<italic>R.coriaria</italic>) on serum glycemic status, apoB, apoA-I and TAC in type 2 diabetic patients. </p></sec><sec><title>Experimental</title><p>
<italic>Materials and methods</italic>
</p><p>This double blind randomized controlled clinical trial was conducted on 41type 2 diabetic volunteers (age: 20-60 years, HbA1c 6-8%, at least 2 years duration of diabetes) who wereall non-smokers, no alcohol and nonusers of antioxidant supplements at least 3 months before the intervention participated and were randomly allocated either to the placebo group or to the sumac group. All of them signed consent form before the start of the study. The study was approved by the Ethics Committee of the Tehran University of Medical Science. Exclusion criteria were the patients reluctance to continue working with, a change in the type or dose of medication, changes in diet or physical activity daily, taking any antioxidant supplement, consuming less than 80% of supplements delivered to the patient at the baseline, recent receiving insulin, pregnancy and lactation, kidney, liver, thyroid diseases and anemia.</p><p>During the intervention, each participant consumed 3.0 g sumac powder daily over 3 months. The participants of the placebo group received the same amount of lactose (<xref rid="B19" ref-type="bibr">19</xref>). The dietary intake of patients evaluated with 24-hour dietary recall questionnaire over 3 days at the beginning and end of study. These completed through telephone interviews to all participants. Also, anthropometric measurements assessed before and after study. Physical activity was measured by an International Physical Activity Questionnaire (<xref rid="B2" ref-type="bibr">2</xref>) at baseline and at the end of the intervention. Blood samples (7 mL) were collected in tubes immediately before and after the intervention under fasting condition (12-14 h). After serum preparation, serum glucose was measured using enzymatic method by commercial kit (Elitech, France) which performed on Hitachi 717 auto analyzer. HbA1c was determined using turbidimetric inhibition immunoassay method with commercial kit (Roche, Germany) on the Cobas. ApoB and apoAI were measured using turbidimetric immunoassay method with commercial kit (Roche, Germany) on the Cobas. TAC was determined using spectrophotometric method as described by Miller and Rice-Evans (<xref rid="B20" ref-type="bibr">20</xref>). </p><p>
<italic>Statistical analysis </italic>
</p><p>All analyses were performed using SPSS statistical software (version 16, SPSS). Normality of variables was assessed by Kolmogorov&#x02013;Smirnov tests. The differences were assessed by the Student&#x02019;s t-test. Differences between groups were compared with independent samples t-test. Differences within groups (before and after intervention) were compared with paired samples t-test. Serum glucose was compared by the Wilcoxon&#x02019;s test. We also calculated the mean of differences (before and after intervention) in serum glucose, HbA1c, apoB, apoA-I, TAC levels apoB/apoA-I ratio. The data are presented as means &#x000b1; standard deviation. Differences were compared for statistical signi&#x0fb01;cance at the level <italic>P</italic>&#x0003c; 0.05.</p></sec><sec sec-type="results"><title>Results</title><p>There were no statistical differences with regard to age, duration of diabetes, weight, BMI, waist circumferences (<xref ref-type="table" rid="T1">Table 1</xref>) and physical activity between sumac (<italic>Rhus coriaria L.</italic>) and placebo groups. Also, energy and nutrients intake were not significantly different between groups at baseline (<xref ref-type="table" rid="T2">Table 2</xref>) and did not change during the study.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Baseline characteristics in sumac and placebo groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="justify" rowspan="1" colspan="1">
<bold>Variable </bold>
</th><th align="justify" rowspan="1" colspan="1">
<bold>Sumac group </bold>
<break/>
<bold>(n=22)</bold>
</th><th align="justify" rowspan="1" colspan="1">
<bold>Placebo group </bold>
<break/>
<bold>(n=19)</bold>
</th><th align="justify" rowspan="1" colspan="1">
<bold>p-values </bold>
</th></tr></thead><tfoot><tr><td align="left" rowspan="1" colspan="1">Duration of Diabetes(year)</td><td align="center" rowspan="1" colspan="1">5.4&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">5.1&#x000b1;3.42</td><td align="center" rowspan="1" colspan="1">0.62</td></tr></tfoot><tbody><tr><td align="left" rowspan="1" colspan="1">Age(year)</td><td align="center" rowspan="1" colspan="1">46.1&#x000b1;8.52</td><td align="center" rowspan="1" colspan="1">47.5&#x000b1;8.4</td><td align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight(Kg)</td><td align="center" rowspan="1" colspan="1">80.1&#x000b1;12.5</td><td align="center" rowspan="1" colspan="1">77.5&#x000b1;13.2</td><td align="center" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI(Kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">29.5&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">29.5&#x000b1;2.2</td><td align="center" rowspan="1" colspan="1">0.95</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist Circumferences(cm)</td><td align="center" rowspan="1" colspan="1">97.9&#x000b1;8.8</td><td align="center" rowspan="1" colspan="1">97.9&#x000b1;9.05</td><td align="center" rowspan="1" colspan="1">0.1</td></tr></tbody></table><table-wrap-foot><p>Data presented as mean &#x000b1; standard deviation.</p></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Baseline energy and nutrients intake in sumac and placebo groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="justify" rowspan="1" colspan="1">
<bold>Variable </bold>
</th><th align="justify" rowspan="1" colspan="1">
<bold>Sumac group </bold>
<break/>
<bold>(n=22)</bold>
</th><th align="justify" rowspan="1" colspan="1">
<bold>Placebo group </bold>
<break/>
<bold>(n=19)</bold>
</th><th align="justify" rowspan="1" colspan="1">
<bold>p-values </bold>
</th></tr></thead><tfoot><tr><td align="left" rowspan="1" colspan="1">Total Fat(g)</td><td align="center" rowspan="1" colspan="1">46.6.6&#x000b1;31.01</td><td align="center" rowspan="1" colspan="1">35.1.6&#x000b1;14.4</td><td align="center" rowspan="1" colspan="1">0.07</td></tr></tfoot><tbody><tr><td align="left" rowspan="1" colspan="1">Energy Intake(Kcal)</td><td align="center" rowspan="1" colspan="1">1579.6&#x000b1;735</td><td align="center" rowspan="1" colspan="1">1287.9&#x000b1;485</td><td align="center" rowspan="1" colspan="1">0.09</td></tr><tr><td align="left" rowspan="1" colspan="1">Total Carbohydrate(g)</td><td align="center" rowspan="1" colspan="1">231.7&#x000b1;149.8</td><td align="center" rowspan="1" colspan="1">174.1&#x000b1;75.5</td><td align="center" rowspan="1" colspan="1">0.064</td></tr><tr><td align="left" rowspan="1" colspan="1">Total Protein(g)</td><td align="center" rowspan="1" colspan="1">66.3&#x000b1;20.7</td><td align="center" rowspan="1" colspan="1">53.4&#x000b1;23.8</td><td align="center" rowspan="1" colspan="1">0.07</td></tr></tbody></table><table-wrap-foot><p>Data presented as mean &#x000b1; standard deviation.</p></table-wrap-foot></table-wrap><p>
<italic>Effect of sumac powder on </italic>
<italic>glycemic status:</italic>
</p><p>Results of serum glucose and HbA1c levels are presented in <xref ref-type="table" rid="T3">Table 3</xref>. Serum glucose was decreased significantly after the intervention compared with baseline (<italic>P</italic>&#x0003c; 0.0001). The mean of differences were signi&#x0fb01;cant between groups (<italic>P</italic>&#x0003c; 0.0001).</p><p>Signi&#x0fb01;cant decrease (<italic>P</italic>= 0.002) in HbA1c in sumac group compare with initial values between groups. There was signi&#x0fb01;cant difference in HbA1c at the end of study between the two groups (<italic>P</italic>= 0.003) and also the mean of differences were signi&#x0fb01;cant between groups (<italic>P</italic>= 0.002).</p><table-wrap id="T3" position="float"><label>Table3</label><caption><p>Serum glucose, HbA1c, apoB, apoA-I, apoB/apoA-I ratio and TAC in sumac and placebo groups at baseline and after the intervention</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="justify" rowspan="1" colspan="1">
<bold>Biochemical parameters</bold>
</th><th align="justify" colspan="3" rowspan="1">
<bold>Sumac group</bold>
<break/>
<bold>(n=22)</bold>
</th><th align="justify" colspan="3" rowspan="1">
<bold>Placebo group</bold>
<break/>
<bold>(n=19)</bold>
</th></tr></thead><tfoot><tr><td align="left" rowspan="1" colspan="1">TAC (&#x003bc;mol/L)</td><td align="center" rowspan="1" colspan="1">2.05 &#x000b1; 0.79</td><td align="center" rowspan="1" colspan="1">2.85 &#x000b1; 0.90<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.000</td><td align="center" rowspan="1" colspan="1">2.34 &#x000b1; 0.69</td><td align="center" rowspan="1" colspan="1">2.30 &#x000b1; 0.60<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.581</td></tr></tfoot><tbody><tr><td align="justify" rowspan="1" colspan="1"/><td align="justify" rowspan="1" colspan="1">
<bold>Before </bold>
</td><td align="justify" rowspan="1" colspan="1">
<bold>After </bold>
</td><td align="justify" rowspan="1" colspan="1">
<bold>p</bold>
<bold>-</bold>
<bold>values</bold>
</td><td align="justify" rowspan="1" colspan="1">
<bold>Before </bold>
</td><td align="justify" rowspan="1" colspan="1">
<bold>After </bold>
</td><td align="justify" rowspan="1" colspan="1">
<bold>p</bold>
<bold>-</bold>
<bold>values</bold>
</td></tr><tr><td align="justify" rowspan="1" colspan="1">glucose (mg/dl)</td><td align="center" rowspan="1" colspan="1">150.14 &#x000b1; 42.03</td><td align="center" rowspan="1" colspan="1">130.55 &#x000b1; 40.55</td><td align="center" rowspan="1" colspan="1">0.000</td><td align="center" rowspan="1" colspan="1">155.47 &#x000b1; 81.83</td><td align="center" rowspan="1" colspan="1">157.10 &#x000b1; 85.09</td><td align="center" rowspan="1" colspan="1">0.048</td></tr><tr><td align="justify" rowspan="1" colspan="1">HbA1c (%)</td><td align="center" rowspan="1" colspan="1">6.75 &#x000b1; 1.2</td><td align="center" rowspan="1" colspan="1">6.18 &#x000b1; 0.83<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">7.30 &#x000b1; 1.31</td><td align="center" rowspan="1" colspan="1">7.31 &#x000b1; 1.32<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.609</td></tr><tr><td align="justify" rowspan="1" colspan="1">apoB (mg/dl)</td><td align="center" rowspan="1" colspan="1">90.45 &#x000b1; 16.38</td><td align="center" rowspan="1" colspan="1">80.03 &#x000b1; 16.22</td><td align="center" rowspan="1" colspan="1">0.000</td><td align="center" rowspan="1" colspan="1">87.79 &#x000b1; 22.61</td><td align="center" rowspan="1" colspan="1">90.02 &#x000b1; 20.53</td><td align="center" rowspan="1" colspan="1">0.137</td></tr><tr><td align="justify" rowspan="1" colspan="1">apoA-I (mg/dl)</td><td align="center" rowspan="1" colspan="1">119.36 &#x000b1; 19.69</td><td align="center" rowspan="1" colspan="1">140.36 &#x000b1; 28.95<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.000</td><td align="center" rowspan="1" colspan="1">119.46 &#x000b1; 3.69</td><td align="center" rowspan="1" colspan="1">118.85 &#x000b1; 3.89<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.028</td></tr><tr><td align="justify" rowspan="1" colspan="1">apoB/apoA-I ratio </td><td align="center" rowspan="1" colspan="1">0.77 &#x000b1; 0.15</td><td align="center" rowspan="1" colspan="1">0.59 &#x000b1; 0.14<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.000</td><td align="center" rowspan="1" colspan="1">0.74 &#x000b1; 0.19</td><td align="center" rowspan="1" colspan="1">0.76 &#x000b1; 0.17<xref ref-type="table-fn" rid="TFN1">*</xref></td><td align="center" rowspan="1" colspan="1">0.100</td></tr></tbody></table><table-wrap-foot><p>The values shown are the mean &#x000b1; SD (standard deviation).</p><fn id="TFN1"><label>*</label><p>Values (after) were signi&#x0fb01;cantly different between groups,<italic> P</italic>&#x0003c; 0.05 (independent samples t-test).</p></fn></table-wrap-foot></table-wrap><p>
<italic>Effect of sumac powder on </italic>
<italic>apoB, apoA-I</italic>
<italic> and </italic>
<italic>apoB/apoA-I </italic>
<italic>ratio</italic>
</p><p>As shown in <xref ref-type="table" rid="T3">Table 3</xref>, in the sumac group, there was a signi&#x0fb01;cant decrease in apoB (<italic>P</italic>&#x0003c; 0.0001), a signi&#x0fb01;cant increase in apoA-I (<italic>P</italic>&#x0003c; 0.0001) and a signi&#x0fb01;cant decrease in the apoB/apoA-I ratio (<italic>P</italic>&#x0003c; 0.0001) after intervention compared with before intervention. There were significant differences in relation to apoA-I and apoB/apoA-I ratio after intervention between groups (<italic>P</italic>= 0.002 and <italic>P</italic>= 0.001, respectively) (<xref ref-type="table" rid="T3">Table 3</xref>). The mean of differences of apoB, apoA-I and apoB/apoA-I ratio between groups were significant (<italic>P</italic>&#x0003c; 0.0001).</p><p>
<italic>Effect of sumac powder on</italic>
<italic> TAC</italic>
</p><p>As shown in <xref ref-type="table" rid="T3">Table 3</xref>, TAC was increased significantly after the intervention compared with baseline (<italic>P</italic>&#x0003c; 0.0001), no such effect were observed in the placebo group. There was signi&#x0fb01;cant difference in TAC at the end of study between the two groups (<italic>P</italic>= 0.026) and also the mean of differences were signi&#x0fb01;cant between groups (<italic>P</italic>&#x0003c; 0.0001).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>In the present study, the mean of differences of serum glucose, HbA1c,apoB, apoA-I, apoB/apoA-I ratio and TAC between groups were significant (<italic>P</italic>&#x0003c; 0.05).</p><p>The evidence for the effect of sumac on blood glucose is mainly based on the results that are obtained from <italic>in-vitro </italic>and <italic>in-vivo</italic> in animal studies and we didn't find any human study about the effect of sumac on glycemic status. The results of the present investigation are similar to the findings of<italic> in-vitro </italic>and animal studies (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B21" ref-type="bibr">21</xref>). Mohammadi <italic>et al</italic>. reported a single dose of administration of the extract of <italic>R. coriaria </italic>fruits reduced PBG significantly in rats and in the long term experiment, on the day of 21, PBG was found to be significantly lower (by 26%)that is compared to diabetic control group.Oral Glucose Tolerance Test (OGTT) results and the ability of inhibiting the &#x003b1;-glucosidases activities by the extract indicate that control of postprandial glucose level might be mediated through the inhibition of carbohydrate digestion or absorption. Also, antihyperglycemic effects of <italic>R.coriaria</italic> fruits may be related to modulation of insulin (INS) secretion or action because no change in the INS and glucose transporter type-4 (GLUT-4) genes expression was described (<xref rid="B9" ref-type="bibr">9</xref>). It has already been reported that <italic>in</italic>-<italic>vitro</italic> hypoglycemic activity of the ethyl acetate extract of fruits of <italic>R. coriaria</italic> is due to inhibition of &#x003b1;-amylase(<xref rid="B21" ref-type="bibr">21</xref>). Sumac contains various substances, phenol acids and flavonoids, such as gallic acid, methyl gallate, kaempferol, and quercetin (<xref rid="B11" ref-type="bibr">11</xref>), that one or all of them may be responsible for the hypoglycaemic activity of sumac (<xref rid="B22" ref-type="bibr">22</xref>). The presence of phenolic acids, such as gallic acid, methyl gallate, or protocatechuic acid in <italic>R. coriaria</italic> support the folkloric use of this plant as spice, food preserving as well as wound cleaning(<xref rid="B11" ref-type="bibr">11</xref>). It has been established that quercetin promotes normalization of the level of glycemia and reduces high blood serum concentrations of cholesterol and low density lipoproteins, seen in diabetes (<xref rid="B23" ref-type="bibr">23</xref>). This effect probably occurred with inhibition of intestinal absorption of glucose through the GLUT-2(<xref rid="B24" ref-type="bibr">24</xref>). However, in one study<italic>, R. coriaria </italic>had no effect on glucose in diabetic animals (<xref rid="B12" ref-type="bibr">12</xref>). <italic>R. verniciflua</italic> extract suppressed effectively the increase of blood glucose level during treatment in diabetic rats (<xref rid="B13" ref-type="bibr">13</xref>). Perhaps in these two previous studies, dose of sumac or duration of study wasn't enough to cause significant changes in the blood glucose.</p><p>Type 2 diabetes mellitus is associated with a high risk for coronary heart disease (CHD). A variety of lipoprotein and apolipoprotein ratios have been proposed that may reflect the balance of cholesterol delivery and removal at the arterial wall and provide an assessment of CHD risk (<xref rid="B25" ref-type="bibr">25</xref>). Apolipoproteins are important structural and functional proteins in lipoprotein particles, which transport lipids. Recent reports from prospective risk studies indicate that the apoB/apoA-I ratio, which re&#x0fb02;ects the cholesterol balance between potentially atherogenic and antiatherogenic lipoprotein particles, is a useful predictor of risk of both non-fatal and fatal myocardial infarction and it has been reported to be a better predictor of CV risk than any of the cholesterol indices (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). In the US population, apolipoprotein measurements signi&#x0fb01;cantly predict CHD death, independently of conventional lipids and other CV risk factors (smoking, dyslipidaemia, hypertension, obesity, diabetes and C-reactive protein) (<xref rid="B27" ref-type="bibr">27</xref>). Furthermore, the predictive ability of apo Bitself for detecting CHD death was better than any of the routine clinical lipid measurements (<xref rid="B27" ref-type="bibr">27</xref>). In the present study, the mean of differences of apoB, apoA-I and apoB/apo A-I ratio between groups were significant (<italic>P</italic>&#x0003c; 0.05). The total value of apoB indicates the number of potentially atherogenic lipoproteins. ApoA-I is important in removing excess cholesterol from tissues and incorporating it into HDL for reverse transport to the liver. The ratio of apoB/apoA-I hence re&#x0fb02;ects the balance of cholesterol transport, so the higher the value, the higher the propensity for cholesterol deposition, and consequently the higher the risk for atherogenesis (<xref rid="B26" ref-type="bibr">26</xref>). In our study, signi&#x0fb01;cant decrease in the apoB/apoA-I ratio and the mean of differences before and after intervention were seen in sumac group significantly (<italic>P</italic>&#x0003c; 0.05), but there weren't significant in placebo group. Evidence from various studies indicates that many herbal medicinal products have potential hypocholesterolaemic activity. The results were obtained from Ho <italic>et al</italic>. studies claimed that glycoprotein isolated from <italic>R. vernici&#x0fb02;ua</italic> fruit for two weeks resulted a signi&#x0fb01;cant decrease in plasma total cholesterol, LDL-C and TG (<xref rid="B14" ref-type="bibr">14</xref>) that these results were similar to the results of Mohammadi <italic>et al</italic>. study (<xref rid="B9" ref-type="bibr">9</xref>). This present study is probably the &#x0fb01;rst study documenting a positive effect of sumac on apolipoproteins level in human. Therefore, more experiments should be performed on human trials to prove this idea.</p><p>In the present study, the antioxidant ability of sumac was proved by measuring TAC that increased significantly after the intervention compared with baseline (<italic>P</italic>&#x0003c; 0.0001). Differences and the mean of differences between placebo group and sumac groups were significant (<italic>P</italic>&#x0003c; 0.05). Different extracts of <italic>R. vernici&#x0fb02;ua</italic> exhibited strong antioxidant activity. Many studies have suggested that extract of <italic>Rhus coriaria L.</italic> fruits may be a source of natural antioxidants (<xref rid="B7" ref-type="bibr">7</xref>). Evidence for this effect is based on results obtained in <italic>in-vitro</italic> experiment (<xref rid="B16" ref-type="bibr">16</xref>) and animal study (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). The results of Chacraborty <italic>et al</italic>. study showed for the &#x0fb01;rst time that the spice sumac is a potent antioxidant which protects humans against oxidative DNA-damage and suggest that GA is may be account for sumac effects (<xref rid="B8" ref-type="bibr">8</xref>).Sumac contains various substances and exactly tannin and gallic acids may be responsible for the antioxidant ability of this plant. Tannic acid extracted from <italic>Rhus chinensis Mill. </italic>could effectively scavenge the O<sup>-2</sup>. Glycoprotein isolated from <italic>R. vernici&#x0fb02;ua</italic> stokes fruit improved the antioxidant levels (<xref rid="B12" ref-type="bibr">12</xref>). <italic>R. verniciflua</italic> stokes (RVS)contains six major low molecular compounds as <italic>p</italic>-coumaric acid, fustin, kaempferol-3-<italic>O</italic>-glucoside, sulfuretin, butein and kaempferol that this extract could contribute to the antioxidant activities and inhibition of intracellular ROS level (<xref rid="B28" ref-type="bibr">28</xref>). Further studies are required to show the most active constituent of sumac fruit.</p><p>In conclusion, sumac consumption may have favorite effect on glycemic status, apoB, apoA-I, TAC levels and apoB/apoA-I ratio and may decrease CVD risk in type 2 diabetic patients. Further studies are required to show the active constituent(s) of sumac<italic>.</italic></p><p>This present study is probably the &#x0fb01;rst study documenting the effect of sumac on apolipoproteins levels in human.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank all the volunteers who participated in this study. This research supported by a grant from Research Institute for Islamic and Complementary Medicine of Iran University of Medical Science.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="webpage"><source>WHO Diabetes</source><date-in-citation>[Cited: 2008]</date-in-citation><comment>URL: http:// <ext-link ext-link-type="uri" xlink:href="http://www.WHO.int/mediacenter/factsheets/fs312/en/">www.WHO.int/mediacenter/factsheets/fs312/en/</ext-link>.</comment></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shidfar</surname><given-names>F</given-names></name><name><surname>Heydari</surname><given-names>I</given-names></name><name><surname>Hajimiresmaiel</surname><given-names>SJ</given-names></name><name><surname>Hosseini</surname><given-names>Sh</given-names></name><name><surname>Shidfar</surname><given-names>Sh</given-names></name><name><surname>Amiri</surname><given-names>F</given-names></name></person-group><article-title>The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients</article-title><source> J. Res. Med. Sci</source><year>2012</year><volume>17</volume><fpage>355</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">23267397</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteghamati</surname><given-names>A</given-names></name><name><surname>Gouya</surname><given-names>MM</given-names></name><name><surname>Abbasi</surname><given-names>M</given-names></name><name><surname>Delavari</surname><given-names>A</given-names></name><name><surname>Alikhani</surname><given-names>S</given-names></name><name><surname>Alaedini</surname><given-names>F</given-names></name><name><surname>Safaie</surname><given-names>A</given-names></name><name><surname>Forouzanfar</surname><given-names>M</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name></person-group><article-title>Prevalence of diabetes and impaired fasting glucose in the adult population of Iran</article-title><source> Diabetes Care</source><year>2008</year><volume>31</volume><fpage>96</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">17921357</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azadmehr</surname><given-names>A</given-names></name><name><surname>Ziaee</surname><given-names>A</given-names></name><name><surname>Ghanei</surname><given-names>L</given-names></name><name><surname>Fallah</surname><given-names>Huseini H</given-names></name><name><surname>Hajiaghaee</surname><given-names>R</given-names></name><name><surname>Tavakoli-far</surname><given-names>B</given-names></name><name><surname>Gholamreza</surname><given-names>Gh</given-names></name></person-group><article-title>A randomized clinical trial study: anti-oxidant, anti-hyperglycemic and anti-hyperlipidemic effects of Olibanum Gum in type 2 diabetic patients</article-title><source> Iran. J. Pharm. Res</source><year>2014</year><volume>13</volume><fpage>1003</fpage><lpage>1009</lpage><pub-id pub-id-type="pmid">25276202</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al</surname><given-names>Mofleh IA</given-names></name></person-group><article-title>Spices, herbal xenobiotics and the stomach: Friends or foes</article-title><source> World J. Gastroenterol</source><year>2010</year><volume>16</volume><fpage>2710</fpage><lpage>2719</lpage><pub-id pub-id-type="pmid">20533590</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayne</surname><given-names>S</given-names></name><name><surname>Mazza</surname><given-names>G</given-names></name></person-group><article-title>Biological activities of extracts from sumac (Rhus spp.): a review</article-title><source> Plant Foods Hum. Nutr</source><year>2007</year><volume>62</volume><fpage>165</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">17909971</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pourahmad</surname><given-names>J</given-names></name><name><surname>Eskandari</surname><given-names>MR</given-names></name><name><surname>Shakibaei</surname><given-names>R</given-names></name><name><surname>Kamalinejad</surname><given-names>M</given-names></name></person-group><article-title>A search for hepatoprotective activity of aqueous extract of Rhus coriaria L. against oxidative stress cytotoxicity</article-title><source> Food Chem. Toxicol</source><year>2010</year><volume>8</volume><fpage>854</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">20036300</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>A</given-names></name><name><surname>Ferk</surname><given-names>F</given-names></name><name><surname>Simi&#x00107;</surname><given-names>T</given-names></name><name><surname>Brantner</surname><given-names>A</given-names></name><name><surname>Dusinsk&#x000e1;</surname><given-names>M</given-names></name><name><surname>Kundi</surname><given-names>M</given-names></name><name><surname>Hoelzl</surname><given-names>C</given-names></name><name><surname>Nersesyan</surname><given-names>A</given-names></name><name><surname>Knasm&#x000fc;ller</surname><given-names>S</given-names></name></person-group><article-title>DNA-protective effects of sumach (Rhus coriaria L.), a common spice: results of human and animal studies</article-title><source> Mutat. Res</source><year>2009</year><volume>661</volume><fpage>10</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">19022266</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammadi</surname><given-names>S</given-names></name><name><surname>Montasser</surname><given-names>Kouhsari S</given-names></name><name><surname>Monavar</surname><given-names>Feshani A</given-names></name></person-group><article-title>Antidiabetic properties of the ethanolic extract of Rhus coriaria fruits in rats</article-title><source> Daru</source><year>2010</year><volume>18</volume><fpage>270</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">22615627</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zargham</surname><given-names>H</given-names></name><name><surname>Zargham</surname><given-names>R</given-names></name></person-group><article-title>Tannin extracted from Sumac inhibits vascular smooth muscle cell migration</article-title><source> Mcgill. J. Med</source><year>2008</year><volume>11</volume><fpage>119</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">19148309</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shabana</surname><given-names>MM</given-names></name><name><surname>El</surname><given-names>Sayed AM</given-names></name><name><surname>Yousif</surname><given-names>MF</given-names></name><name><surname>El</surname><given-names>Sayed AM</given-names></name><name><surname>Sleem</surname><given-names>AA</given-names></name></person-group><article-title>Bioactive constituents from Harpephyllum caffrum Bernh and Rhus coriaria L</article-title><source> Pharmacogn. Mag</source><year>2011</year><volume>7</volume><fpage>298</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">22262932</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capcarova</surname><given-names>M</given-names></name><name><surname>Slamecka</surname><given-names>J</given-names></name><name><surname>Abbas</surname><given-names>K</given-names></name><name><surname>Kolesarova</surname><given-names>A</given-names></name><name><surname>Kalafova</surname><given-names>A</given-names></name><name><surname>Valent</surname><given-names>M</given-names></name><name><surname>Filipejova</surname><given-names>T</given-names></name><name><surname>Chrastinova</surname><given-names>L</given-names></name><name><surname>Ondruska</surname><given-names>L</given-names></name><name><surname>Massanyi</surname><given-names>P</given-names></name></person-group><article-title>Effects of dietary inclusion of Rhus coriaria on internal milieu of rabbits</article-title><source> J. Anim. Physiol. Anim. Nutr</source><year>2012</year><volume>96</volume><fpage>459</fpage><lpage>465</lpage></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>CH</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>GX</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Hong</surname><given-names>MH</given-names></name><name><surname>Shin</surname><given-names>YC</given-names></name><name><surname>Kim</surname><given-names>GJ</given-names></name><name><surname>Ko</surname><given-names>SG</given-names></name></person-group><article-title>Antihyperglycemic activity of herb extracts on streptozotocin-induced diabetic rats</article-title><source> Biosci. Biotechnol. Biochem</source><year>2006</year><volume>70</volume><fpage>2556</fpage><lpage>2559</lpage><pub-id pub-id-type="pmid">17031059</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>PS</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Lim</surname><given-names>KT</given-names></name></person-group><article-title>Hypolipidemic and antioxidative effects of the plant glycoprotein (36 kDa) from Rhus verniciflua stokes fruit in Triton WR-1339-induced hyperlipidemic mice</article-title><source> Biosci. Biotechnol. Biochem</source><year>2006</year><volume>70</volume><fpage>447</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">16495662</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiyici</surname><given-names>A</given-names></name><name><surname>Okudan</surname><given-names>N</given-names></name><name><surname>G&#x000f6;kbel</surname><given-names>H</given-names></name><name><surname>Belviranli</surname><given-names>M</given-names></name></person-group><article-title>The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats</article-title><source> J. Med. Food</source><year>2010</year><volume>13</volume><fpage>725</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">20388041</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Candan</surname><given-names>F</given-names></name><name><surname>Sokmen</surname><given-names>A</given-names></name></person-group><article-title>Effects of Rhus coriaria L (Anacardiaceae) on lipid peroxidation and free radical scavenging activity</article-title><source> Phytother. Res</source><year>2004</year><volume>18</volume><fpage>84</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">14750207</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shidfar</surname><given-names>F</given-names></name><name><surname>Aghasi</surname><given-names>M</given-names></name><name><surname>Vafa</surname><given-names>M</given-names></name><name><surname>Heydari</surname><given-names>I</given-names></name><name><surname>Hosseini</surname><given-names>S</given-names></name><name><surname>Shidfar</surname><given-names>S</given-names></name></person-group><article-title>Effects of combination of zinc and vitamin A supplementation on serum fasting blood sugar, insulin, apoprotein B and apoprotein A-I in patients with type I diabetes</article-title><source> Int. J. Food Sci. Nutr</source><year>2010</year><volume>61</volume><fpage>182</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">20151940</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shidfar</surname><given-names>F</given-names></name><name><surname>Froghifar</surname><given-names>N</given-names></name><name><surname>Vafa</surname><given-names>M</given-names></name><name><surname>Rajab</surname><given-names>A</given-names></name><name><surname>Hosseini</surname><given-names>S</given-names></name><name><surname>Shidfar</surname><given-names>S</given-names></name><name><surname>Gohari</surname><given-names>M</given-names></name></person-group><article-title>The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients</article-title><source> Int. J. Food Sci. Nutr</source><year>2011</year><volume>62</volume><fpage>289</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">21138408</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shidfar</surname><given-names>F</given-names></name><name><surname>Ebrahimi</surname><given-names>ShS</given-names></name><name><surname>Hosseini</surname><given-names>Sh</given-names></name><name><surname>Heydari</surname><given-names>I</given-names></name><name><surname>Shidfar</surname><given-names>Sh</given-names></name><name><surname>Hajhassani</surname><given-names>G</given-names></name></person-group><article-title>The effects of Berberis vulgaris fruit extract on serum lipoproteins, apoB, apoA-I, homocysteine, glycemic control and total antioxidant capacity in type 2 diabetic patients</article-title><source> Iran. J. Pharm. Res</source><year>2012</year><volume>11</volume><fpage>643</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">24250489</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>NJ</given-names></name><name><surname>Rice-Evans</surname><given-names>C</given-names></name><name><surname>Davies</surname><given-names>MJ</given-names></name><name><surname>Gopinathan</surname><given-names>V</given-names></name><name><surname>Milner</surname><given-names>A</given-names></name></person-group><article-title>A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates</article-title><source> Clin. Sci</source><year>1993</year><volume>84</volume><fpage>407</fpage><lpage>412</lpage><pub-id pub-id-type="pmid">8482045</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giancarlo</surname><given-names>R</given-names></name><name><surname>Nadjafif</surname><given-names>F</given-names></name></person-group><article-title>Hypoglycaemic activity of two spices extract: Rhus coriaria, Bunium persicum Boiss</article-title><source> Nat. Prod. Res</source><year>2006</year><volume>20</volume><fpage>882</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">16753927</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sales</surname><given-names>PM</given-names></name><name><surname>Souza</surname><given-names>PM</given-names></name><name><surname>Simeoni</surname><given-names>LA</given-names></name><name><surname>Silveira</surname><given-names>D</given-names></name></person-group><article-title>&#x003b1;-Amylase inhibitors: a review of raw material and isolated compounds from plant source</article-title><source> J. Pharm. Sci</source><year>2012</year><volume>15</volume><fpage>141</fpage><lpage>183</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>NuralievIu</surname><given-names>N</given-names></name><name><surname>Avezov</surname><given-names>GA</given-names></name></person-group><article-title>The efficacy of quercetin in alloxan diabetes</article-title><source> Eksp. Klin. Farmakol</source><year>1992</year><volume>55</volume><fpage>42</fpage><lpage>44</lpage></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skopec</surname><given-names>MM</given-names></name><name><surname>Green</surname><given-names>AK</given-names></name><name><surname>Karasov</surname><given-names>WH</given-names></name></person-group><article-title>Flavonoids have differential effects on glucose absorption in rats (Rattusnorvegicus) and American robins (Turdismigratorius)</article-title><source> J. Chem. Ecol</source><year>2010</year><volume>36</volume><fpage>236</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">20145981</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyton</surname><given-names>JR</given-names></name><name><surname>Goldberg</surname><given-names>RB</given-names></name><name><surname>Mazzone</surname><given-names>T</given-names></name><name><surname>Weinstock</surname><given-names>RS</given-names></name><name><surname>Polis</surname><given-names>A</given-names></name><name><surname>Rosenberg</surname><given-names>E</given-names></name><name><surname>Tershakovec</surname><given-names>AM</given-names></name></person-group><article-title>Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetes</article-title><source> J. Clin. Lipidol</source><year>2008</year><volume>2</volume><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">21291711</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra-Johnson</surname><given-names>J</given-names></name><name><surname>Romero-Corral</surname><given-names>A</given-names></name><name><surname>Somers</surname><given-names>VK</given-names></name><name><surname>Lopez-Jimenez</surname><given-names>F</given-names></name><name><surname>Walldius</surname><given-names>G</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Hell&#x000e9;nius</surname><given-names>ML</given-names></name><name><surname>Fisher</surname><given-names>RM</given-names></name></person-group><article-title>ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects</article-title><source> Eur. Heart J</source><year>2007</year><volume>28</volume><fpage>2637</fpage><lpage>2643</lpage><pub-id pub-id-type="pmid">17766927</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra-Johnson</surname><given-names>J</given-names></name><name><surname>Fisher</surname><given-names>RM</given-names></name><name><surname>Romero-Corral</surname><given-names>A</given-names></name><name><surname>Somers</surname><given-names>VK</given-names></name><name><surname>Lopez-Jimenez</surname><given-names>F</given-names></name><name><surname>Ohrvik</surname><given-names>J</given-names></name><name><surname>Walldius</surname><given-names>G</given-names></name><name><surname>Hellenius</surname><given-names>ML</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name></person-group><article-title>Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population</article-title><source> Eur. Heart J</source><year>2009</year><volume>30</volume><fpage>710</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">18676970</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>CH</given-names></name><name><surname>Jun</surname><given-names>CY</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>CH</given-names></name><name><surname>Cho</surname><given-names>K</given-names></name><name><surname>Ko</surname><given-names>SG</given-names></name></person-group><article-title>Rhus verniciflua stokes extract: radical scavenging activities and protective effects on H2O2-induced cytotoxicity in macrophage RAW 264.7 cell lines</article-title><source> Biol. Pharm. Bull</source><year>2006</year><volume>29</volume><fpage>1603</fpage><lpage>1607</lpage><pub-id pub-id-type="pmid">16880612</pub-id></element-citation></ref></ref-list></back></article>